Implantica
37.8 SEK +10.2%1 investor is following this company
Implantica is active in medical technology. The company specializes in the development of medical devices. The product portfolio is broad and includes implantable medical instruments, which are further used for the treatment of diseases that affect the esophagus. In addition to the main business, service and related ancillary services are also offered, especially focused on eHealth. Implantica operates worldwide, with the largest presence in North America and Europe.
Revenue
15.7M
EBIT %
-1,548.94 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
IMP A SDB
Daily low / high price
34.65 / 38.1
SEK
Market cap
44.72B SEK
Turnover
3.71M SEK
Volume
99K
Latest videos
Financial calendar
Interim report
2024-08-21
Interim report
2024-11-15
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Peter Forsell | 47.4 % | 47.4 % |
Handelsbanken Fonder | 9.3 % | 9.3 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Implantica announces further expansion of RefluxStop™ access in the UK NHS public Hospital Network
Bulletin from the Annual General Meeting of Implantica AG
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
![Implantica, Audiocast with teleconference, Q1, 2024](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/0f2b1030-5989-4834-aa87-4b0cc0d42ab9.png)